Adage Capital Partners
AURA icon

Adage Capital Partners’s Aura Biosciences AURA Stock Holding History

Adage Capital Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.7M Hold
4,881,125
– – 0.05% 349
2025
Q4 		$26.6M Hold
4,881,125
– – 0.04% 407
2025
Q3 		$30.2M Hold
4,881,125
– – 0.05% 358
2025
Q2 		$30.6M Hold
4,881,125
– – 0.05% 346
2025
Q1 		$28.6M Hold
4,881,125
– – 0.05% 337
2024
Q4 		$40.1M Hold
4,881,125
– – 0.07% 264
2024
Q3 		$43.5M Sell
4,881,125
-3,875
-0.1% -$33.2K 0.08% 256
2024
Q2 		$36.9M Buy
4,885,000
+420,000
+9% +$3.08M 0.07% 282
2024
Q1 		$35.1M Buy
4,465,000
+240,000
+6% +$1.99M 0.07% 313
2023
Q4 		$37.4M Buy
4,225,000
+1,350,000
+47% +$11.4M 0.08% 258
2023
Q3 		$25.8M Buy
2,875,000
+165,000
+6% +$1.78M 0.06% 325
2023
Q2 		$33.5M Hold
2,710,000
– – 0.07% 271
2023
Q1 		$25.1M Buy
2,710,000
+577,261
+27% +$6M 0.06% 360
2022
Q4 		$22.4M Buy
2,132,739
+681,538
+47% +$8.68M 0.05% 392
2022
Q3 		$26.3M Buy
1,451,201
+174,582
+14% +$2.64M 0.07% 331
2022
Q2 		$18.1M Sell
1,276,619
-20,400
-2% -$338K 0.04% 458
2022
Q1 		$28.5M Buy
1,297,019
+41,539
+3% +$791K 0.05% 351
2021
Q4 		$21.3M Buy
+1,255,480
New +$22.4M 0.04% 443

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners's AURA Position: Q1 2026 in Review

Adage Capital Partners held its Aura Biosciences (AURA) position steady in Q1 2026 at 4,881,125 shares worth $32.7M. The position accounts for 0.05% of the portfolio, ranked #349.

Adage Capital Partners first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $43.5M in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Adage Capital Partners held 4,881,125 shares of Aura Biosciences worth $32.7M as of Q1 2026.
  • Adage Capital Partners left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up 0.05% of Adage Capital Partners's portfolio in Q1 2026, its #349 holding.
  • Adage Capital Partners first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Adage Capital Partners's Aura Biosciences position peaked at $43.5M in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.